Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Sales (2020 - 2025)

Historic Return on Sales for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 0.09%.

  • Eton Pharmaceuticals' Return on Sales fell 1500.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.1% for FY2024, which is 700.0% down from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Return on Sales stood at 0.09%, which was down 1500.0% from 0.14% recorded in Q2 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Return on Sales peaked at 0.43% during Q1 2021, and registered a low of 7.86% during Q3 2021.
  • For the 5-year period, Eton Pharmaceuticals' Return on Sales averaged around 0.7%, with its median value being 0.1% (2024).
  • Examining YoY changes over the last 5 years, Eton Pharmaceuticals' Return on Sales showed a top increase of 2358400bps in 2021 and a maximum decrease of -25621600bps in 2021.
  • Over the past 5 years, Eton Pharmaceuticals' Return on Sales (Quarter) stood at 0.17% in 2021, then plummeted by -37bps to 0.11% in 2022, then crashed by -171bps to 0.08% in 2023, then skyrocketed by 32bps to 0.05% in 2024, then tumbled by -67bps to 0.09% in 2025.
  • Its Return on Sales was 0.09% in Q3 2025, compared to 0.14% in Q2 2025 and 0.88% in Q1 2025.